1Prasad A, et al. Contemporary trend of acute kidney injury incidence and incremental costs among US patients undergoing percutaneous coronary procedures. Catheter Cardiovasc Interv. 2020 Nov;96(6):1184-1197.
2Castro D, Dang TT. Reducing contrast-induced acute kidney injury in the cath lab. Poster presentation at ACC National Cardiovascular Data Registry (NCDR) 2018 Annual Conference.
3Thukral N. Kidney care protocols in the cath lab. Transcatheter Cardiovascular Therapeutics 2019 Presentation. Accessed on October 14, 2019 from: https://www.tctmd.com/slide/aki-reduction-cath-lab-protocol-development-implementation-and-outcomes.
4Turner C, Tucker PA. Real-world impact of a quality improvement program for AKI prevention in the cardiac cath lab. SCAI Scientific Sessions Virtual Conference. Catheter & Cardiovasc Interv. 2020;95 (Supplement 2): S112-S113.
5Cameron A, Espinosa TJ. Reducing contrast-induced acute kidney injury in a cardiac catherization laboratory: a quality improvement initiative. SCAIScientificSessionsVirtualConference. Catheter&CardiovascInterv. 2020;95(Supplement 2):S25.
6Bunney R, Saenger E, Shah C, et al. Contemporary use of contrast dye reduction technology in a tertiary academic hospital: patient characteristics and acute kidney injury outcomes following percutaneous coronary interventions. Poster presented at ACC Quality Summit 2019; Poster 2018-063.
7Kutschman R. Clinical and economic outcomes of a comprehensive clinical quality initiative for reducing acute kidney injury in chronic kidney disease patients undergoing coronary angiography. JACC. 2019;74 (13 Suppl): B605.
8Sattar A, et al. Impact of using DyeVert Plus on incidence of acute kidney injury after cardiac catheterizations with coronary interventions in high risk patients. ACC Annual Meeting 2018; Charleston, WV.
9Briguori C, Golino M, Porchetta N, et al. Impact of a contrast media volume control device on acute kidney injury rate in patients with acute coronary syndrome. Catheter & Cardiovasc Interv. 2020 Jul 18. doi: 10.1002/ccd.29136.
10Desch S, et al. Impact of a novel contrast reduction system on contrast savings in coronary angiography – The DyeVert randomized controlled trial. Int J of Cardiol. 2018;(257):50-53.